Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
NCT ID: NCT04396002
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2019-06-01
2026-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Glaucoma and Visual Field Loss on Life Space
NCT03673644
Effects of Primary Open-angle Glaucoma on Visual-motor Coordination
NCT06692205
Matching Glaucoma With Impaired Cognition
NCT03695224
Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
NCT01262209
Ability of Patients With Low Vision to Properly Instill Eye Drops
NCT00760240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 2: To determine whether differences exist between people with healthy eyes and patients with POAG in seeing under dim illumination (objective measures of visual function) and to determine whether such differences are associated with life space.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary Open-Angle Glaucoma
Patients diagnosed with primary open-angle glaucoma.
Life Space Questionnaire
This 9-item questionnaire is interested in finding out how much a person gets out and about and the spatial extent of the person's typical life space, i.e., what is the usual range of places in which the person engages in activities within the designated time frame.
Low Luminance Questionnaire
This 32-item questionnaire is interested in finding out problems that involve vision under different lighting conditions or feelings that people have about your vision under different lighting conditions.
Contrast sensitivity under dim illumination
Participants will be presented with visual targets of different contrast under dim illumination and asked to report when they see the target.
Visual field under dim illumination (MAIA)
Sensitivity in the central visual area will be assessed under dim illumination
Macular Pigment Optical Density (MPOD)
Participants will be asked to look at a fixation target and the density of their macular pigment will be assessed.
Dark Adaptation
After adapting to a dark environment, participants will be exposed a bright flask of light. the time needed for them to recover their sensitivity will be measured.
Control
Participants with healthy eyes.
Life Space Questionnaire
This 9-item questionnaire is interested in finding out how much a person gets out and about and the spatial extent of the person's typical life space, i.e., what is the usual range of places in which the person engages in activities within the designated time frame.
Low Luminance Questionnaire
This 32-item questionnaire is interested in finding out problems that involve vision under different lighting conditions or feelings that people have about your vision under different lighting conditions.
Contrast sensitivity under dim illumination
Participants will be presented with visual targets of different contrast under dim illumination and asked to report when they see the target.
Visual field under dim illumination (MAIA)
Sensitivity in the central visual area will be assessed under dim illumination
Macular Pigment Optical Density (MPOD)
Participants will be asked to look at a fixation target and the density of their macular pigment will be assessed.
Dark Adaptation
After adapting to a dark environment, participants will be exposed a bright flask of light. the time needed for them to recover their sensitivity will be measured.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Life Space Questionnaire
This 9-item questionnaire is interested in finding out how much a person gets out and about and the spatial extent of the person's typical life space, i.e., what is the usual range of places in which the person engages in activities within the designated time frame.
Low Luminance Questionnaire
This 32-item questionnaire is interested in finding out problems that involve vision under different lighting conditions or feelings that people have about your vision under different lighting conditions.
Contrast sensitivity under dim illumination
Participants will be presented with visual targets of different contrast under dim illumination and asked to report when they see the target.
Visual field under dim illumination (MAIA)
Sensitivity in the central visual area will be assessed under dim illumination
Macular Pigment Optical Density (MPOD)
Participants will be asked to look at a fixation target and the density of their macular pigment will be assessed.
Dark Adaptation
After adapting to a dark environment, participants will be exposed a bright flask of light. the time needed for them to recover their sensitivity will be measured.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No diagnosis of eye disease
Exclusion Criteria
* Cognitive impairment that would preclude ability to take the tests
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lyne Racette
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyne Racette, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
300001552
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.